Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0%
April 16, 2024 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 16, 2024 (GLOBE NEWSWIRE) -- The Global Testosterone Replacement Therapy Market Size is to grow from USD 1.98 Billion in 2023 to USD 2.93 Billion by 2033, at a...
With 5.80% CAGR, Hormone Replacement Therapy (HRT) Market Size worth $33.22 Billion by 2030 | Vantage Market Research
November 07, 2023 03:58 ET
|
Vantage Market Research
WASHINGTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Hormone Replacement Therapy Market is valued at USD 21.16 Billion in 2022 and is expected to reach USD 33.22 Billion by 2030 at a CAGR of 5.80% over...
Product Innovation Boosts Growth of Testosterone Replacement Therapy Market, Projected to Reach $1.85 Billion in 2023
July 26, 2023 04:23 ET
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Hormone Therapy Market Set to Reach $23.65 Billion by 2027 with Growing Demand for Innovative Treatments and Rising Hormone Imbalance Cases
July 24, 2023 07:13 ET
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Hormone Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The market is projected to grow from $17.34...
Global Hormone Replacement Therapy Market Report 2022 to 2027: Surging Incidences of Hormone Imbalance Disorders in the Geriatric and Neonatal Populations is Primarily Driving Growth
December 26, 2022 05:58 ET
|
Research and Markets
Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Hormone Replacement Therapy Market Size & Share to Surpass $ 28.6 Billion by 2028 | Vantage Market Research
December 13, 2022 13:23 ET
|
Vantage Market Research
WASHINGTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Global Hormone Replacement Therapy Market is valued at USD 20.1 Billion in 2021 and is projected to reach a value of USD 28.6 Billion by 2028 at a...
Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction
August 18, 2022 16:05 ET
|
Clarus Therapeutics Holdings, Inc.
Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total prescription growth for JATENZO® increased 23% sequentially and increased 72% year-over-year ...
Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)
July 28, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., July ...
Global Hormone Replacement Therapy Market to Surpass US$ 20,576.3 Million by 2030, Says Coherent Market Insights (CMI)
July 27, 2022 08:40 ET
|
CMI
Seattle, July 27, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global hormone replacement therapy market is estimated to be valued at US$ 13,556.7 million in 2022 and is...
Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)
May 18, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list this patent...